Treatment of patients with multiple myeloma over 65 yr: more tolerability or better response?-Reference-Cited by-同舟云学术

Treatment of patients with multiple myeloma over 65 yr: more tolerability or better response?

Published:2014-10-18 Issue:5 Volume:94 Page:424-430
ISSN:0902-4441
Container-title:European Journal of Haematology
language:en
Short-container-title:Eur J Haematol

Author:

Tarkun Pinar¹,Atalay Figen²,Atesoglu Elif Birtas¹,Mehtap Ozgur³,Simsek Melih¹,Terzi Esra¹,Geduk Ayfer¹,Balli Fatih¹,Batman Adnan¹,Baydemir Canan¹,Hacihanefioglu Abdullah¹

Affiliation:

1. Department of Hematology; Kocaeli University School of Medicine; Kocaeli Turkey

2. Department of Hematology; Baskent University School of Medicine; İstanbul Turkey

3. Department of Hematology; Kocaeli State Hospital; Kocaeli Turkey

Publisher

Wiley

Subject

Hematology,General Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/ejh.12448/fullpdf

Reference23 articles.

1. Improved survival in multiple myeloma and the impact of novel therapies;Kumar;Blood,2008

2. Patterns of multiple myeloma during the past 5 decades: stable incidence rates for all age groups in the population but rapidly changing age distribution in the clinic;Turesson;Mayo Clin Proc,2010

3. Thalidomide for previously untreated elderly patients with multiple myeloma: meta-analysis of 1685 individual patient data from six randomized clinical trials;Fayers;Blood,2011

4. Improvement in survival of older adults with multiple myeloma: results of an updated period analysis of SEER data;Pulte;Oncologist,2011

5. Combination chemotherapy versus melphalan plus prednisone as treatment for multiple myeloma: an overview of 6633 patients from 27 randomized trials. Myeloma Trialists’ Collaborative Group;Myeloma Trialists’ Collaborative Group;J Clin Oncol,1998

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The casual relationship between autoimmune diseases and multiple myeloma: a Mendelian randomization study;Clinical and Experimental Medicine;2024-04-02

2. Bortezomib use and outcomes for the treatment of multiple myeloma;Internal Medicine Journal;2020-09

3. Ex Vivo Models Simulating the Bone Marrow Environment and Predicting Response to Therapy in Multiple Myeloma;Cancers;2020-07-22

4. Identification and expression of MMSA-8, and its clinical significance in multiple myeloma;Oncology Reports;2017-04-28

5. Ginkgolic Acid C 17:1, Derived from Ginkgo biloba Leaves, Suppresses Constitutive and Inducible STAT3 Activation through Induction of PTEN and SHP-1 Tyrosine Phosphatase;Molecules;2017-02-13